docetaxel anhydrous has been researched along with Barrett Esophagus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimura, T; Kitagawa, H; Makino, I; Maruzen, S; Nakamura, K; Ninomiya, I; Ohta, T; Okamoto, K; Oyama, K; Takamura, H | 1 |
| Andoh, T; Arakawa, K; Itoh, H; Kobayashi, K; Sakamoto, K; Sato, H; Sunose, Y; Suto, Y; Takeyoshi, I; Tomizawa, N | 1 |
1 review(s) available for docetaxel anhydrous and Barrett Esophagus
| Article | Year |
|---|---|
[A case of skeletal muscle metastasis on the left thigh after esophagectomy for esophageal adenocarcinoma in Barrett' s esophagus].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Barrett Esophagus; Cisplatin; Docetaxel; Esophageal Neoplasms; Esophagectomy; Fatal Outcome; Humans; Male; Middle Aged; Muscle, Skeletal; Recurrence; Taxoids | 2015 |
1 other study(ies) available for docetaxel anhydrous and Barrett Esophagus
| Article | Year |
|---|---|
[A case of Barrett's esophageal carcinoma treated with combined therapy].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Barrett Esophagus; Chemoradiotherapy; Cisplatin; Docetaxel; Esophageal Neoplasms; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Taxoids | 2012 |